Speakers

Lior Raviv

Chief Technology Officer • Pluri

Lior Raviv joined Pluristem in 2011 and currently serves as Chief Technology Officer. Prior to that, Mr Raviv served as Projects manager & Product development Team leader at Pluristem in charge of new technologies and process development. Prior to joining Pluristem and during the years 2010-2011, Mr Raviv held the position of R&D Analytical Researcher at Teva Pharmaceutical Industries. Mr Raviv holds an M.Med.Sec in pharmacology from Ben Gurion University and a B.S.c in Biotechnology Engineering from Ben Gurion University.

Also speaking

Becky Johnson-Kent

DIRECTOR OF COMMERCIAL PARTNERSHIPS AND HEAD OF WOMEN IN ADVANCED THERAPIES • Phacilitate

Ryan Leahy

Vice President of Research • Phacilitate

Susanne Kintscher

Ph.D., MS&T Lead Lentiviral Vector Manufacturing • Miltenyi Bioindustry

Event Info

Image

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.
Image

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.